BioAcyl Corp

WIKINDX Resources  

Panagioti, E., Klenerman, P., Lee, L. N., van der Burg, S. H., & Arens, R. (2018). Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections. Forntiers in immunology, 9. 
Added by: Dr. Enrique Feoli (17/07/2020, 10:42)   Last edited by: Dr. Enrique Feoli (17/07/2020, 10:48)
Resource type: Journal Article
DOI: 10.3389/fimmu.2018.00276
ID no. (ISBN etc.): 1664-3224
BibTeX citation key: Panagioti2018
View all bibliographic details
Categories: Zotero
Subcategories: Inmunidad de mucosas
Creators: Arens, Klenerman, Lee, Panagioti, van der Burg
Collection: Forntiers in immunology
Views: 2/216
Abstract
For many years the focus of prophylactic vaccines was to elicit neutralizing antibodies but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with HIV, CMV, and HCV. Currently, a variety of promising prophylactic vaccines, capable of inducing substantial vaccine-specific T cell responses, are investigated in preclinical and clinical studies. There is compelling evidence that protection by T cells is related to the magnitude and breadth of the T cell response, to the type and homing properties of the memory T cell subsets, and to their cytokine polyfunctionality and metabolic fitness. In this review, we evaluated these key factors that determine the qualitative and quantitative properties of CD4+ and CD8+ T cell responses in the context of chronic viral disease and prophylactic vaccine development. Elucidation of the mechanisms underlying T cell-mediated protection against chronic viral pathogens will facilitate the development of more potent, durable and safe prophylactic T cell-based vaccines.
Added by: Dr. Enrique Feoli  Last edited by: Dr. Enrique Feoli
Notes
Publisher: Frontiers in immunology
  
WIKINDX 6.12.1 | Total resources: 1701 | Username: -- | Bibliography: WIKINDX Master Bibliography | Style: American Psychological Association (APA) | Time Zone: America/Costa_Rica (-06:00)